News

DNA Script Expands Series B to $89M

Casdin Capital leads the $50M extension; funding will support commercial launch of SYNTAX™️ — the world’s first enzymatic DNA printer.

Xilio Therapeutics Appoints Paul J. Clancy to its Board of Directors

Mr. Clancy brings significant strategic, financial and operational leadership experience in the biotechnology and pharmaceutical industry

Synaffix Announces Third Deal Expansion by ADC Therapeutics

Synaffix B.V. announces that ADC Therapeutics SA has expanded its existing collaboration to explore additional applications, including DAR1, of Synaffix’ site-specific conjugation technologies

Sonde Health Launches New Voice-Enabled Health Screening Tool to Help Employers Return to Work During the Global Pandemic

Sonde One combines 6-second voice analysis, COVID-19 questionnaire, and body temperature reading in one app

Micropsi Industries Secures Two New Specialized Investors

Our Existing Backers Will Also Supply Fresh Investment

Akili Announces FDA Clearance of EndeavorRx™ for Children with ADHD, the First Prescription Treatment Delivered Through a Video Game

Shown to improve attention function, EndeavorRx is backed by data from five clinical studies, including a prospective, randomized controlled trial

iOnctura Appoints Industry Veteran Dr. Joanna Horobin as Chair

Computers modelled on the human brain

Comment from Kai Beckmann, member, executive board, Merck KGaA

Galecto Appoints New Chair and Strengthens Board of Directors

Appoints Amit Munshi as Chair, deeply experienced industry executive, CEO of Arena Pharmaceuticals

Xilio Therapeutics Appoints Martin H. Huber, M.D as Chief Medical Officer

To Lead XTX201 (Tumor-Selective IL-2) and XTX101 (Tumor-Selective aCTLA-4) into the Clinic while Xilio Continues to Advance its Tumor-Selective Cytokine Pipeline

Akili Announces ENDEAVORTM Digital Attention Treatment is Now Available for Children with Attention Deficit Hyperactivity Disorder (ADHD) under FDA’s COVID-19 Enforcement Discretion Guidance

ENDEAVORTM (AKL-T01) is now available for use by children with attention deficit hyperactivity disorder (ADHD) and their families

FoRx Therapeutics AG Raises EUR 10 Million Seed Round

First Company to Develop a Pipeline of Drugs Targeting DNA Replication Stress for Cancer Seasoned Biotech Executive Colin Goddard Joins as Executive Chairman

Seeqc Gains Over $11 Million in Funding to Introduce Fully Digital Quantum Computing

Spinout Announces Investment From M Ventures, the Strategic, Corporate Venture Capital Arm of Merck KGaA, Darmstadt, Germany, to Deliver Scalable, Energy-Efficient Quantum Computing Systems

Scipio bioscience raises €6.0 M Series A financing

To develop and launch a kit dedicated to sample preparation for single-cell RNAsequencing

Artios Pharma Strengthens Clinical Development Team with Senior Appointments

Artios Pharma Limited today announces the appointment of Bryony Harrop as Vice President (VP) of Clinical Development

iOnctura Expands its Clinical Advisory Board

iOnctura SA announces the addition of new members to its Clinical Advisory Board (CAB)

First programmable memristor computer aims to bring AI processing down from the cloud

Circuit elements that store information in their electrical resistances enable a brain-like form of computing, storing and processing information in the same place